Article
A Cohort Study of 38 Classic Wiskott-Aldrich Syndrome Cases with Six Novel Mutations.
Journal of clinical immunology - 20 Feb 2026
Razaghian Anahita, Badalzadeh Mohsen, Hamidieh Amir Ali, Shokouhi Shoormasti Raheleh, Behniafard Nasrin, Houshmand Massoud, Moradi Leila, Alavi Samin, Behfar Maryam, Movahedi Masoud, Gharagozlou Mohammad, Rostami Tahereh, Moussavi Farideh, Fallahpour Morteza, Shariat Mansoureh, Parvaneh Nima, Shafiei Alireza, Ahanchian Hamid, Babaei Delara, Bemanian Mohammad Hassan, Radmehr Roshanak, Khademi Reyhaneh, Shamlou Somayeh, Fazlollahi Mohammad Reza, Pourpak Zahra
Abstract excerpt
PURPOSE: Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency characterized by eczema, microthrombocytopenia, and recurrent infections. This study evaluates the frequency of clinical manifestations and overall outcomes in WAS patients, comparing those who received hematopoietic stem cell transplantation (HSCT) with those who did not. METHODS: Thirty-eight boys with a definite diagnosis of WAS were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
